Biotech Values

[10nisman]

as my previous post states - i think this is MNTA's way of getting teva's capabilities in the public domain - either they have analytics to meet criteria (and then in their opinion infringed patents) or they don't - and the public knows teva has not performed the proper tests for approval - and the lawsuit is without merit

I completely agree and think this is a brilliant move by CW and team. Teva either has the ability to obtain approval and MNTA will delay/prevent tLovenox from arriving on the market with the lawsuit, Teva fights the lawsuit and shows the world its abilities or Teva realizes it doesn't want to waste resources fighting the lawsuit and they eventually pull their ANDA.

Dew, what are your thoughts?

10nis